Skip to main content


Biotech Stock Mailbag: Idenix vs. Pharmasset?

Biotech columnist Adam Feuerstein answers readers' questions and concerns about health care and drug-related stocks.

5 Stocks Under $10 With Big Upside Potential

These under-$10 stocks look poised to trade higher from current levels.

Biotech Stock Live Chat

TheStreet's biotech columnist Adam Feuerstein is holding a live, interactive discussion about biotech stock investing.

Neoprobe Stock Gaps Up On Today's Open (NEOP)

Shares of Neoprobe Corporation (AMEX:NEOP) were gapping up Thursday morning with an open price 17.9% higher than Wednesday's closing price. The stock closed at $2.63 yesterday and opened today's trading at $3.10.

Neoprobe Proves A Short Seller Wrong

FDA acceptance of Neoprobe's application for a lymph-node mapping agent is a defeat for a hedge fund manager who waged a campaign to stop the review.

Breaking News

Ford Makes a Major Change

The legacy automaker has just made a decision that will affect consumers buying its electric vehicles via a lease.

Tesla Q2 Deliveries Slump To 254,695 As Shanghai Shutdown, Supply Chain Snarls Take Toll

Tesla said it had a record rate of production in June, but supply chain disruption and the closure of its Shanghai gigafactory triggered a slump in Q2 deliveries.

Summers, Others Cite Growing Chance of Recession

GDP shrank an annualized 1.6% in the first quarter, and some experts anticipate another drop in the second quarter.

Coinbase Faces A New Scandal

The platform denies selling proprietary customer data and announces it is expanding into several European countries.